- Home
- STOK vs GTN Comparison
STOK vs GTN Comparison
Compare STOK & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- GTN
- Stock Information
- Founded
- STOK 2014
- GTN 1897
- Country
- STOK United States
- GTN United States
- Employees
- STOK N/A
- GTN N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- GTN Broadcasting
- Sector
- STOK Health Care
- GTN Industrials
- Exchange
- STOK Nasdaq
- GTN Nasdaq
- Market Cap
- STOK 517.0M
- GTN 463.2M
- IPO Year
- STOK 2019
- GTN N/A
- Fundamental
- Price
- STOK $9.87
- GTN $3.90
- Analyst Decision
- STOK Strong Buy
- GTN Strong Buy
- Analyst Count
- STOK 5
- GTN 3
- Target Price
- STOK $24.50
- GTN $6.17
- AVG Volume (30 Days)
- STOK 694.7K
- GTN 1.5M
- Earning Date
- STOK 05-13-2025
- GTN 05-08-2025
- Dividend Yield
- STOK N/A
- GTN 8.06%
- EPS Growth
- STOK N/A
- GTN N/A
- EPS
- STOK 0.88
- GTN 2.34
- Revenue
- STOK $190,908,000.00
- GTN $3,603,000,000.00
- Revenue This Year
- STOK $44.17
- GTN N/A
- Revenue Next Year
- STOK $20.00
- GTN $14.83
- P/E Ratio
- STOK $10.88
- GTN $1.70
- Revenue Growth
- STOK 2333.81
- GTN 9.08
- 52 Week Low
- STOK $5.35
- GTN $2.91
- 52 Week High
- STOK $17.58
- GTN $6.61
- Technical
- Relative Strength Index (RSI)
- STOK 55.15
- GTN 48.67
- Support Level
- STOK $9.09
- GTN $3.87
- Resistance Level
- STOK $9.83
- GTN $4.18
- Average True Range (ATR)
- STOK 0.61
- GTN 0.18
- MACD
- STOK -0.05
- GTN -0.02
- Stochastic Oscillator
- STOK 51.93
- GTN 17.76
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About GTN Gray Television Inc.
Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios.